GlassScriptPhysician profile
Alfonso B Barragan
NPI 1851433775
$1,233.30
in general payments reported to CMS, 2019-2025
15 companies · $275 in 2025
The $275 reported for 2025 was less than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $93.39 · 2021: $261 · 2023: $160 · 2024: $276 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $710.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $418.23 | 2021-2025 | |
| Amgen INC. | $165.86 | 2024-2025 | Krystexxa |
| Acumed LLC | $138.28 | 2019 | |
| Pacira Therapeutics, INC. | $86.83 | 2019-2020 | |
| Bioventus LLC | $68.90 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $58.12 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Vertex Pharmaceuticals Incorporated | $51.78 | 2025 | |
| Horizon Therapeutics Plc | $51.15 | 2023 | Krystexxa |
| Innovation Technologies INC | $49.71 | 2024 | Irrisept |
| Endo Pharmaceuticals INC. | $38.88 | 2021 | |
| Stryker Corporation | $28.21 | 2025 | Conextions Tr Tendon Repair System-Implant Mechanism |
| Dynasplint Systems INC. | $23.11 | 2025 | Dynasplint |
| Exsomed Corporation | $20.27 | 2020 | |
| Axogen | $17.30 | 2025 | |
| Merck Sharp & Dohme LLC | $16.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfonso Barragan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.